No Data
No Data
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma
Lacklustre Performance Is Driving Pacira BioSciences, Inc.'s (NASDAQ:PCRX) 26% Price Drop
Pacira BioSciences Analyst Ratings
Express News | Pacira Biosciences Inc : Truist Securities Cuts Target Price to $8 From $30
Express News | Pacira Biosciences Inc : Truist Securities Cuts to Sell From Buy
No Data
No Data